Related Experiment Video
Updated: Oct 3, 2025

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United States
Maria Karlsson1, Joseph D Lutgring1, Uzma Ansari1
1Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Abstract:
Carbapenem-resistant Enterobacterales (CRE) are a growing public health concern due to resistance to multiple antibiotics and potential to cause health care-associated infections with high mortality. Carbapenemase-producing CRE are of particular concern given that carbapenemase-encoding genes often are located on mobile genetic elements that may spread between different organisms and species. In this study, we performed phenotypic and genotypic characterization of CRE collected at eight U.S. sites participating in active population- and laboratory-based surveillance of carbapenem-resistant organisms. Among 421 CRE tested, the majority were isolated from urine (n = 349, 83%). Klebsiella pneumoniae was the most common organism (n = 265, 63%), followed by Enterobacter cloacae complex (n = 77, 18%) and Escherichia coli (n = 50, 12%). Of 419 isolates analyzed by whole genome sequencing, 307 (73%) harbored a carbapenemase gene; variants of blaKPC predominated (n = 299, 97%). The occurrence of carbapenemase-producing K. pneumoniae, E. cloacae complex, and E. coli varied by region; the predominant sequence type within each genus was ST258, ST171, and ST131, respectively. None of the carbapenemase-producing CRE isolates displayed resistance to all antimicrobials tested; susceptibility to amikacin and tigecycline was generally retained.
Insights
Carbapenem-resistant Enterobacterales (CRE) pose a significant threat, with carbapenemase-producing strains spreading easily. This study analyzed CRE isolates, finding KPC carbapenemase genes in most, with some susceptibility to amikacin and tigecycline.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- Carbapenem-resistant Enterobacterales (CRE) are a critical global health concern, particularly carbapenemase-producing strains.
- These resistant organisms can cause severe healthcare-associated infections with high mortality rates.
- The mobile nature of carbapenemase genes facilitates inter-organismal and inter-species spread.
Purpose of the Study:
- To characterize the phenotypic and genotypic features of CRE isolates.
- To identify the prevalence of carbapenemase genes and specific organisms.
- To understand regional variations and antimicrobial susceptibility patterns.
Main Methods:
- Phenotypic and genotypic characterization of CRE isolates from eight U.S. surveillance sites.
- Whole genome sequencing of 419 CRE isolates.
- Antimicrobial susceptibility testing.
Main Results:
- The majority of 421 CRE isolates were from urine (83%).
- Klebsiella pneumoniae (63%), Enterobacter cloacae complex (18%), and Escherichia coli (12%) were the most common species.
- 73% of isolates harbored carbapenemase genes, predominantly blaKPC variants (97%).
- Regional variations in carbapenemase-producing K. pneumoniae, E. cloacae complex, and E. coli were observed, with predominant sequence types ST258, ST171, and ST131, respectively.
- No carbapenemase-producing CRE isolates were resistant to all tested antimicrobials; amikacin and tigecycline susceptibility was generally retained.
Conclusions:
- Carbapenemase-producing CRE, particularly KPC-variant producers, are prevalent in the U.S.
- Specific sequence types are dominant within key Enterobacterales species.
- Retained susceptibility to amikacin and tigecycline offers potential therapeutic options.
More Related Videos
09:44Characterization of a Pathogenic Escherichia coli Strain Derived from Oreochromis spp. Farms Using Whole-Genome Sequencing
Published on: December 23, 2022
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025